Fredun Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	649.81	6.37	10.72	29.47	19.38
Short-Term Investments	-	52.86	2.41	1.51	1.08
Trading Asset Securities	-	-	8.08	3.08	0.58
Cash & Short-Term Investments	649.81	59.23	21.21	34.05	21.04
Cash Growth	997.13%	179.31%	-37.73%	61.84%	81.16%
Accounts Receivable	926.85	1,771	648.49	345.6	902.73
Other Receivables	-	-	-	-	0.16
Receivables	935.56	1,776	650.95	347.11	903.79
Inventory	2,698	2,399	1,750	1,501	464.6
Restricted Cash	-	0.5	0.38	3.38	0.26
Other Current Assets	698.31	45.02	149.49	276.34	136.81
Total Current Assets	4,982	4,280	2,572	2,162	1,526
Property, Plant & Equipment	1,176	524.89	461.53	386.26	322.82
Long-Term Investments	20.07	12.43	4.66	0.03	0.03
Other Intangible Assets	6.32	4.27	4.2	3.08	0.56
Other Long-Term Assets	236.43	52.98	33.61	21.32	19.98
Total Assets	6,421	4,874	3,076	2,573	1,870
Accounts Payable	875.83	1,448	629.47	593.43	486.17
Accrued Expenses	-	60.62	27.98	27.47	24.45
Short-Term Debt	-	1,506	867.6	677.09	186.19
Current Portion of Long-Term Debt	1,661	69.21	59.52	33.98	-
Current Portion of Leases	-	12.37	-	-	-
Current Income Taxes Payable	95.41	71.16	55.35	42.9	27.91
Other Current Liabilities	336.47	113.84	28.36	21.7	12.79
Total Current Liabilities	2,969	3,281	1,668	1,397	737.5
Long-Term Debt	563.1	96.13	127.98	154.4	420.39
Pension & Post-Retirement Benefits	-	18.56	11.62	9.97	10.03
Long-Term Deferred Tax Liabilities	65.48	44.84	41.37	38.43	14.31
Other Long-Term Liabilities	42.56	19.77	12.04	9.67	7.05
Total Liabilities	3,640	3,460	1,861	1,609	1,189
Common Stock	54.73	47.22	46.99	45.32	44.33
Additional Paid-In Capital	-	738.23	714.27	549.69	454.12
Retained Earnings	-	628.39	437.73	285.48	180.04
Comprehensive Income & Other	2,726	-0	15.72	83.27	2.13
Total Common Equity	2,781	1,414	1,215	963.76	680.61
Shareholders' Equity	2,781	1,414	1,215	963.76	680.61
Total Liabilities & Equity	6,421	4,874	3,076	2,573	1,870
Total Debt	2,224	1,684	1,055	865.47	606.59
Net Cash (Debt)	-1,574	-1,625	-1,034	-831.41	-585.54
Net Cash Per Share	-295.48	-349.98	-222.73	-185.67	-141.03
Filing Date Shares Outstanding	5.47	4.72	4.7	4.53	4.43
Total Common Shares Outstanding	5.47	4.72	4.7	4.53	4.43
Working Capital	2,013	998.56	903.72	765.54	788.99
Book Value Per Share	508.23	299.43	258.50	212.64	153.54
Tangible Book Value	2,775	1,410	1,211	960.68	680.05
Tangible Book Value Per Share	507.08	298.53	257.60	211.96	153.42
Land	-	5.24	5.24	5.24	5.24
Buildings	-	235.73	220.93	210.02	210.02
Machinery	-	547.57	391.07	289.59	198.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.